Texas 2015 84th Regular

Texas Senate Bill SB1560 Engrossed / Bill

Filed 04/30/2015

Download
.pdf .doc .html
                    By: Zaffirini S.B. No. 1560


 A BILL TO BE ENTITLED
 AN ACT
 relating to the regulation of chemical dependency treatment
 facilities and certain other facilities.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 164.003(6), Health and Safety Code, is
 amended to read as follows:
 (6)  "Mental health professional" means a:
 (A)  "physician" as defined by Section 571.003;
 (B)  "licensed professional counselor" as defined
 by Section 503.002, Occupations Code;
 (C)  "chemical dependency counselor" as defined
 by Section 504.001, Occupations Code;
 (D)  "psychologist" offering "psychological
 services" as defined by Section 501.003, Occupations Code;
 (E)  "registered nurse" licensed under Chapter
 301, Occupations Code;
 (F)  "advanced practice registered nurse" as
 defined by Section 301.152 ["vocational nurse" licensed under
 Chapter 301], Occupations Code;
 (G)  "licensed marriage and family therapist" as
 defined by Section 502.002, Occupations Code; [and]
 (H)  "social worker" as defined by Section
 505.002, Occupations Code; and
 (I)  "physician assistant" licensed under Chapter
 204, Occupations Code.
 SECTION 2.  Section 164.009(e), Health and Safety Code, is
 amended to read as follows:
 (e)  A chemical dependency facility may not represent or
 recommend that a prospective patient should be admitted to a
 facility for treatment unless and until:
 (1)  the prospective patient has been evaluated, in
 person, by a mental health professional; and
 (2)  a [the] mental health professional determines that
 the patient meets the facility's admission standards.
 SECTION 3.  Sections 462.009(a) and (b), Health and Safety
 Code, are amended to read as follows:
 (a)  A treatment facility licensed by the department under
 Chapter 464 may not provide treatment to a patient without the
 patient's legally adequate consent. [A patient receiving treatment
 in a treatment facility is entitled to refuse a medication,
 therapy, or treatment unless:
 [(1)     the patient is younger than 18 years of age, the
 patient is admitted under Section 462.022(a)(3)(A), and the
 patient's parent, managing conservator, or guardian consents to the
 medication, therapy, or treatment on behalf of the patient;
 [(2)     the patient has been adjudicated to be
 incompetent to manage the patient's personal affairs or to make a
 decision to refuse the medication, therapy, or treatment and the
 patient's guardian of the person or another person legally
 authorized to consent to medical treatment consents to the
 medication, therapy, or treatment on behalf of the patient; or
 [(3)     a physician treating the patient determines that
 the medication is necessary to prevent imminent serious physical
 harm to the patient or to another individual and the physician
 issues a written order, or a verbal order if authenticated in
 writing by the physician within 24 hours, to administer the
 medication to the patient.]
 (b)  The executive commissioner by rule shall prescribe
 standards for obtaining a patient's legally adequate consent under
 this section, including rules prescribing reasonable efforts to
 obtain a patient's consent and requiring documentation for those
 efforts. [The decision of a guardian or of a person legally
 authorized to consent to medical treatment on the patient's behalf
 under Subsection (a)(2) must be based on knowledge of what the
 patient would desire, if known.]
 SECTION 4.  Subchapter A, Chapter 462, Health and Safety
 Code, is amended by adding Sections 462.010, 462.011, 462.012, and
 462.013 to read as follows:
 Sec. 462.010.  CONSENT TO MEDICATION. Consent to the
 administration of prescription medication given by a patient
 receiving treatment in a treatment facility licensed by the
 department under Chapter 464 or by a person authorized by law to
 consent on behalf of the patient is valid only if:
 (1)  the consent is given voluntarily and without
 coercive or undue influence;
 (2)  the patient and, if appropriate, the patient's
 representative authorized by law to consent on behalf of the
 patient are informed in writing that consent may be revoked; and
 (3)  the consent is evidenced in the patient's clinical
 record by a signed form prescribed by the treatment facility or by a
 statement of the treating physician or a person designated by the
 physician that documents that consent was given by the appropriate
 person and the circumstances under which the consent was obtained.
 Sec. 462.011.  RIGHT TO REFUSE MEDICATION. (a)  Each
 patient receiving treatment in a treatment facility licensed by the
 department under Chapter 464 has the right to refuse unnecessary or
 excessive medication.
 (b)  Medication may not be used by the treatment facility:
 (1)  as punishment; or
 (2)  for the convenience of the staff.
 Sec. 462.012.  MEDICATION INFORMATION. (a)  The executive
 commissioner by rule shall require the treating physician of a
 patient admitted to a treatment facility licensed by the department
 under Chapter 464 or a person designated by the physician to provide
 to the patient in the patient's primary language, if possible,
 information relating to prescription medications ordered by the
 physician.
 (b)  At a minimum, the required information must:
 (1)  identify the major types of prescription
 medications; and
 (2)  specify for each major type:
 (A)  the conditions the medications are commonly
 used to treat;
 (B)  the beneficial effects on those conditions
 generally expected from the medications;
 (C)  side effects and risks associated with the
 medications;
 (D)  commonly used examples of medications of the
 major type; and
 (E)  sources of detailed information concerning a
 particular medication.
 (c)  If the treating physician designates another person to
 provide the information under Subsection (a), then, not later than
 two working days after that person provides the information,
 excluding weekends and legal holidays, the physician shall meet
 with the patient and, if appropriate, the patient's representative
 who provided consent for the administration of the medications
 under Section 462.010, to review the information and answer any
 questions.
 (d)  The treating physician or the person designated by the
 physician shall also provide the information to the patient's
 family on request, but only to the extent not otherwise prohibited
 by state or federal confidentiality laws.
 Sec. 462.013.  LIST OF MEDICATIONS. (a)  On the request of a
 patient, a person designated by the patient, or the patient's legal
 guardian or managing conservator, if any, the facility
 administrator of a treatment facility licensed by the department
 under Chapter 464 shall provide to the patient, the person
 designated by the patient, and the patient's legal guardian or
 managing conservator, a list of the medications prescribed for
 administration to the patient while the patient is in the treatment
 facility. The list must include for each medication:
 (1)  the name of the medication;
 (2)  the dosage and schedule prescribed for the
 administration of the medication; and
 (3)  the name of the physician who prescribed the
 medication.
 (b)  The list must be provided before the expiration of four
 hours after the facility administrator receives a written request
 for the list from the patient, a person designated by the patient,
 or the patient's legal guardian or managing conservator, if any. If
 sufficient time to prepare the list before discharge is not
 available, the list may be mailed before the expiration of 24 hours
 after discharge to the patient, the person designated by the
 patient, and the patient's legal guardian or managing conservator.
 (c)  A patient or the patient's legal guardian or managing
 conservator, if any, may waive the right of any person to receive
 the list of medications while the patient is participating in a
 research project if release of the list would jeopardize the
 results of the project.
 SECTION 5.  Section 462.025(h)(4), Health and Safety Code,
 is amended to read as follows:
 (4)  "Screening" means the process a treatment facility
 uses to determine whether a prospective patient presents sufficient
 signs, symptoms, or behaviors to warrant a more in-depth assessment
 by a qualified professional after the patient is admitted.
 SECTION 6.  The following provisions of the Health and
 Safety Code, including provisions amended by S.B. No. 219, Acts of
 the 84th Legislature, Regular Session, 2015, are repealed:
 (1)  Sections 462.009(c), (d), (e), (f), and (g); and
 (2)  Section 462.025(h)(2).
 SECTION 7.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution.  If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2015.